Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Nestlé Divests Peanut Allergy Brand to Stallergenes Greer
Nestlé Health Science announced on September 5 its divestment of Palforzia, a children’s peanut allergy drug, to Stallergenes Greer International AG. According to data captured in the LevinPro HC database, this transaction represents the 77th Pharmaceuticals acquisition of 2023. Palforzia became the first drug approved by the FDA for peanut allergy in children in January 2020. At the time, it was projected that the drug could reach $1.28 billion in sales by 2024. Backed by B-FLEXION, Stallergenes Greer International AG is a global biopharmaceutical company. It is based in Baar, Switzerland and specializes in the diagnosis and treatment of respiratory allergies through... Read More »
VitalPoint Technologies Acquires Herban Healing
Houston-based VitalPoint Technologies, Inc. (VPT) announced on August 31 it acquired Herban Healing, LLC. The financial terms of the transaction were not disclosed. Herban Healing is a Texas-based biopharmaceutical company focused on healthcare products centered around CBD. Co-Founders Kyle Williams and Jennifer Gillelan established Herban Healing with the goal of addressing the opioid epidemic. Founded in 2019, the company operates two locations in Cypress, Texas and one in North Spring, Texas. VitalPoint Technologies was established to conduct research, develop solutions and provide education on alternative healthcare options. VPT is a tech-enabled innovative Healthcare... Read More »
MB2 Dental Solutions Expands Into 600 Locations
On August 30, MB2 Dental Solutions announced the opening of its 600th practice location, Highland Creek Family Dental – South, in Lafayette, Indiana. The practice is operated by Dr. Shane Cope, a general dentist. MB2 Dental initially partnered with Dr. Cope in August 2022 when MB2 purchased Highland Creek Family Dental. Since then, Dr. Cope was able to build a second location. MB2 Dental Solutions, a portfolio company of middle-market private equity firm Charlesbank Capital Partners since February 2021, partners with dentists and specialists. Founded in 2007, MB2 offers general dentistry services, orthodontics, cosmetic dentistry and oral surgery. According to data... Read More »
Panoramic Health Acquires Kidney Specialists of South Texas
Panoramic Health announced on August 29 its acquisition of Kidney Specialists of South Texas (KSST). KSST is a nephrology practice with two locations in Corpus Christi, Texas. According to its website, the practice has seven physicians and one nurse practitioner on staff. Panoramic Health is a physician-led kidney care organization. Panoramic Health’s Clinical Research division partners with sponsors and clinical research organizations to bring treatments to patients with kidney disease. By leveraging Panoramic Health’s integrated value-based care platform, KSST will enhance care coordination to optimize patient engagement and achieve better clinical and... Read More »
Agios Pharmaceuticals Acquires Alnylam’s siRNA Blood Disease Program
Agios Pharmaceuticals Inc. announced its acquisition of Alnylam Pharmaceuticals, Inc.’s siRNA blood disease program targeting TMPRSS6, a gene that makes protein. According to data captured in the LevinPro HC database, this transaction marks the 105th Biotechnology acquisition in 2023. Alnylam is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002. According to its most recent financial report, the company achieved net product revenues of $894 million during FY 2022. Agios is the pioneering leader in pyruvate kinase (PK) activation... Read More »
Cybin Acquires Small Pharma
Cybin, Inc. announced on August 28 its acquisition of Small Pharma, Inc. a London-based biotechnology company progressing a pipeline of short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Small Pharma has a portfolio of clinical-stage DMT-based assets, SPL026 and SPL028. Small Pharma was granted an Innovation Passport designation for SPL026 from the U.K. Medicines and Healthcare products Regulatory Agency and has a pipeline of proprietary preclinical assets. Cybin is a biopharmaceutical company advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions. Headquartered in Toronto and founded in... Read More »
Worsening Healthcare Workforce Shortage May Deepen
The severe shortage of healthcare professionals has been attributed to numerous factors. Job burnout, retirements and the impact of the COVID-19 pandemic are all well-known factors contributing to the crisis that is only expected to get worse. However, one factor has gotten virtually no attention: the certifications, qualifications and education needed for healthcare careers are not available for many due to a lack of instructors. Consider the situation at nursing schools. An American Association of Colleges of Nursing report revealed U.S. nursing schools turned away 91,938 qualified applicants for undergraduate and graduate nursing programs in 2021, primarily due to a lack of... Read More »
Healthcare Subsectors Drive Double-Digit M&A Decline in 2023
There is no shortage of subsectors contributing to the overall double-digit percentage decline in healthcare M&A activity in 2023. According to the LevinPro HC database, there have been 1,299 healthcare M&A deals this year through July 31. This represents an 12% drop compared with the 1,481 transactions recorded during the same period in 2022. The 2023 total represents a 5% increase from the 1,240 deals posted in 2021 through July 31. Some of the subsectors that have contributed to the M&A activity decline this year include Contract Development Manufacturing Organizations (CDMO), healthcare staffing firms, infusion services companies, primary & value-based care... Read More »
Dr. Daniel Rychlik Acquires Oma Fertility Santa Barbara
Fertility specialist Dr. Daniel Rychlik personally acquired Oma Fertility Santa Barbara. According to data captured in the LevinPro HC database, this acquisition represents the 267th Physician Medical Groups transaction of the year, 20 of them in the OB/GYN specialty. Although five of Oma Fertility’s nationwide clinics were acquired by a corporate entity, Dr Rychlik felt it important that his Santa Barbara clinic maintain a patient-centric approach without being acquired by another corporate entity. Financial terms of the deal were not disclosed. Oma Fertility is a full-service fertility clinic that offers fertility care and treatments. The company was founded in 2020 and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
